We are live on ! Find out more
DVC

Deer VII & Co Portfolio holdings

AUM $317M
1-Year Est. Return 30.89%
This Fund
S&P 500
This Quarter Est. Return
+1.64%
1 Year Est. Return
+30.89%
3 Year Est. Return
+241.3%
5 Year Est. Return
+1,036.06%
10 Year Est. Return
AUM
$224M
AUM Growth
-$130M
Cap. Flow
-$119M
Cap. Flow %
-52.82%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
TWTR
Twitter, Inc.
TWTR
+$467K

Top Sells

Rank Stock Value
1
CRTO icon
Criteo
CRTO
+$118M
2
TPST icon
Tempest Therapeutics
TPST
+$876K
3
DARE icon
Dare Bioscience
DARE
+$8.53K

Sector Composition

Rank Sector Weight
1 Technology 75.48%
2 Healthcare 24.31%
3 Communication Services 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WIX icon
1
WIX.com
WIX
$2.45B
$129M 57.46%
7,935,978
TWOU
2
DELISTED
2U Inc
TWOU
$40.5M 18.02%
86,487
TPST icon
3
Tempest Therapeutics
TPST
$13.9M
$38.5M 17.15%
793
-25
-3% -$876K
VSTM icon
4
Verastem
VSTM
$547M
$10.1M 4.52%
99,197
XLRN
5
DELISTED
Acceleron Pharma
XLRN
$5.29M 2.36%
175,075
DARE icon
6
Dare Bioscience
DARE
$17.8M
$633K 0.28%
1,389
-16
-1% -$8.53K
TWTR
7
DELISTED
Twitter, Inc.
TWTR
$479K 0.21%
+10,326
New +$467K
CRTO icon
8
Criteo
CRTO
$1.06B
-3,498,513
Closed -$118M

Similar funds

Deer VII & Co's Q3 2014 Portfolio in Review

As of Q3 2014, Deer VII & Co held 8 positions worth $224M, down 37% from $354M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Deer VII & Co withdrew a net $119M in Q3 2014, closing 1 position and reducing 2 holdings. Its most notable exit was Criteo, an estimated $118M position sold in full.

By sector, the portfolio is most concentrated in Technology at 75% of assets, up from 56% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Deer VII & Co opened a new position in Twitter, Inc. worth $479K.

  • Deer VII & Co's largest Q3 2014 buy was Twitter, Inc.: 10,326 shares worth $479K.
  • Deer VII & Co's biggest Q3 2014 reduction was Tempest Therapeutics, cutting an estimated $876K.
  • Deer VII & Co fully exited Criteo in Q3 2014, selling an estimated $118M.
  • Deer VII & Co's ten largest holdings make up 100% of its $224M portfolio in Q3 2014.
  • Deer VII & Co opened 1 new position and closed 1 in Q3 2014.
  • Deer VII & Co's portfolio value fell 37% quarter-over-quarter to $224M.

Based on Deer VII & Co's 13F filing for Q3 2014, filed 13 Nov 2014.